The evaluation of fAGP and six tumor makers to diagnose malignancy indicated that CA19-9 ( p = 0.0019) and SPan-1 ( p = 0.0241) had a statistically significant difference in pancreas cancer but that no such significance was observed in the other factors nor in the other diseases with all factors even though there were a few exceptions that were close to being statistically significant.
← all excerpts
α<sub>1</sub>-Acid Glycoprotein with Highly Fucosylated Glycans as a Potential Diagnostic Marker for Early Detection of Hepatobiliary and Pancreatic Cancers.
1
—
—